Manabu Takamatsu Selected Research

Manabu Takamatsu Research Topics

Disease

14	Neoplasms (Cancer) 10/2022 - 11/2007
3	Pancreatic Neoplasms (Pancreatic Cancer) 09/2022 - 10/2021
3	Neoplasm Metastasis (Metastasis) 09/2022 - 11/2007
3	Adenocarcinoma 10/2021 - 01/2019
3	Hemorrhage 12/2018 - 11/2011
2	Infections 09/2014 - 01/2012
2	Hepatitis 09/2014 - 10/2013
2	Hypothermia 10/2011 - 03/2011
2	Ischemia 10/2011 - 03/2011
1	Sarcoma (Soft Tissue Sarcoma) 10/2022
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 05/2022
1	Catheter-Related Infections 12/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2021
1	Granuloma 12/2021
1	Dihydropyrimidine Dehydrogenase Deficiency 10/2021
1	Enteritis 10/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Pancreatoblastoma 01/2021
1	Synovial Sarcoma (Synovioma) 12/2020
1	Microsatellite Instability 12/2020
1	Myositis (Idiopathic Inflammatory Myopathies) 11/2020
1	Erythema 11/2020
1	Adenoma (Adenomas) 09/2020
1	Polyps 09/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 08/2020
1	Enterocolitis 06/2020
1	Rectal Neoplasms (Rectal Cancer) 06/2020
1	Megacolon 06/2020
1	Angioedema 06/2019
1	Hypertension (High Blood Pressure) 06/2019
1	Lymphatic Metastasis 01/2019
1	Hemangioma (Angioma) 05/2017
1	Sepsis (Septicemia) 11/2014
1	Peritonitis 11/2014
1	Hypoxia (Hypoxemia) 09/2014
1	Massive Hepatic Necrosis 09/2014
1	Adenocarcinoma of Lung 05/2014
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 10/2013
1	Autoimmune Hepatitis 10/2013

Drug/Important Bio-Agent (IBA)

4	Hematoxylin (Haematoxylon)IBA 01/2013 - 03/2011
4	Eosine Yellowish-(YS) (Eosin)IBA 01/2013 - 03/2011
3	Galectin 3 (LGALS3)IBA 01/2013 - 03/2011
2	Proteins (Proteins, Gene)FDA Link 12/2021 - 12/2020
2	CateninsIBA 01/2021 - 10/2013
2	Messenger RNA (mRNA)IBA 08/2015 - 01/2012
2	1-methyltryptophanIBA 08/2015 - 09/2013
2	CytokinesIBA 08/2015 - 09/2013
2	DNA (Deoxyribonucleic Acid)IBA 07/2015 - 03/2011
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 11/2014 - 09/2014
2	KynurenineIBA 09/2014 - 08/2012
2	Biotin (Vitamin H)FDA Link 10/2011 - 03/2011
1	Anaplastic Lymphoma KinaseIBA 10/2022
1	ErbB Receptors (EGF Receptor)IBA 10/2022
1	ParaffinIBA 09/2022
1	Codon (Codons)IBA 09/2022
1	Formaldehyde (Formol)FDA Link 09/2022
1	intervenolinIBA 12/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2021
1	obinutuzumabIBA 12/2021
1	Bendamustine Hydrochloride FDA Link 12/2021
1	Monoclonal AntibodiesIBA 12/2021
1	UracilIBA 10/2021
1	dihydrouracilIBA 10/2021
1	Gemcitabine FDA Link 10/2021
1	Butyrates (Butyrate)IBA 01/2021
1	Cyclin D1IBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 11/2020
1	Bleomycin (Blenoxane)FDA LinkGeneric 11/2020
1	Cisplatin (Platino)FDA LinkGeneric 11/2020
1	Etoposide (VP 16)FDA LinkGeneric 11/2020
1	theasinensin AIBA 09/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Keratins (Keratin)IBA 01/2019
1	LipidsIBA 12/2018
1	Capsules (Microcapsules)IBA 05/2017
1	Hemostatics (Antihemorrhagics)IBA 05/2017
1	ChemokinesIBA 11/2014
1	Oxygen (Dioxygen)IBA 09/2014
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2014
1	Insulin (Novolin)FDA Link 05/2014
1	Fenofibrate (CiL)FDA LinkGeneric 05/2014
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 05/2014
1	Insulin-Like PeptidesIBA 05/2014

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 09/2022 - 06/2019
2	Neoadjuvant Therapy 09/2022 - 10/2021
2	Therapeutics 09/2014 - 05/2005
1	Pancreatectomy 09/2022
1	Adjuvant Chemotherapy 05/2022
1	Peritoneal Dialysis 12/2021
1	Immunotherapy 01/2021
1	Hepatectomy 08/2020
1	Ileostomy 06/2020
1	Colectomy 06/2020
1	Salpingo-oophorectomy 04/2018
1	Ligation 11/2014
1	Punctures 11/2014